Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist.
The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.
One in four older US veterans report being diagnosed with cardiovascular disease in their lifetime, according to study findings.
The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.
Coffee drinking timing is associated with all-cause and cardiovascular disease-specific mortality risk, according to study findings.
A Louisiana resident has died after being hospitalized with bird flu in December of last year, marking the first known US death from the virus.
The Food and Drug Administration has approved the OraQuick® HIV Self-Test to include individuals 14 years of age and older.
Doxycycline postexposure prophylaxis initiation is associated with decreases in sexually transmitted infections.
The first-ever US FDA guidelines on lead in baby food are under fire from health experts who argue the limits are too lenient and fail to protect children from harmful exposure to toxic metals.
Rates of pertussis in the US are surging, with more than 32,000 cases reported as of mid-December — about 6 times more than at this time last year and more than have been reported since 2014.
Fecal calprotectin concentrations were increased in over a quarter of patients with symptomatic microscopic colitis and were linked to worse symptoms.
The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.